AU6183700A - Erythromycin a derivatives - Google Patents

Erythromycin a derivatives

Info

Publication number: AU6183700A
Authority: AU; Australia
Prior art keywords: erythromycin; derivatives
Prior art date: 1999-08-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU61837/00A

Inventor

Toshifumi Asaka

Masato Kashimura

Akira Manaka

Tomohiro Sugimoto

Tetsuya Tanikawa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Taisho Pharmaceutical Co Ltd

Original Assignee

Taisho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-06

Filing date

2000-07-31

Publication date

2001-03-05

2000-07-31 Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd

2001-03-05 Publication of AU6183700A publication Critical patent/AU6183700A/en

Status Abandoned legal-status Critical Current

Links

ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Communicable Diseases (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AU61837/00A 1999-08-06 2000-07-31 Erythromycin a derivatives Abandoned AU6183700A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP11/223554		1999-08-06
JP22355499		1999-08-06
PCT/JP2000/005144 WO2001010878A1 (en)	1999-08-06	2000-07-31	Erythromycin a derivatives

Publications (1)

Publication Number	Publication Date
AU6183700A true AU6183700A (en)	2001-03-05

Family

ID=16799988

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU61837/00A Abandoned AU6183700A (en)	1999-08-06	2000-07-31	Erythromycin a derivatives

Country Status (2)

Country	Link
AU (1)	AU6183700A (en)
WO (1)	WO2001010878A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020115621A1 (en)	2000-08-07	2002-08-22	Wei-Gu Su	Macrolide antibiotics
AU2003234650A1 (en)	2002-05-31	2003-12-19	Janssen Pharmaceutica N.V.	3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents
EP2772254A3 (en)	2003-03-10	2015-03-11	Optimer Pharmaceuticals, Inc.	Novel Antibacterial Agents
US20080318878A1 (en) *	2004-09-27	2008-12-25	Biswajit Das	Antibacterial Agents
JP5698979B2 (en)	2007-10-25	2015-04-08	センプラファーマシューティカルズ，インコーポレイテッド	Process for preparing macrolide antibacterial agents
CN105616437A (en)	2008-10-24	2016-06-01	森普拉制药公司	Biodefenses using triazole-containing macrolides
US9937194B1 (en)	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
CN108310000A (en)	2009-09-10	2018-07-24	森普拉制药公司	Treat malaria, the method for tuberculosis and MAC diseases
EP3009442B1 (en)	2010-03-22	2019-06-19	Cempra Pharmaceuticals, Inc.	Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en)	2010-05-20	2017-08-28	Cempra Pharmaceuticals Inc	PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
US9815863B2 (en)	2010-09-10	2017-11-14	Cempra Pharmaceuticals, Inc.	Hydrogen bond forming fluoro ketolides for treating diseases
RU2658050C2 (en)	2012-03-27	2018-06-19	Семпра Фармасьютикалз, Инк.	Parenteral formulations for administering macrolide antibiotics
JP6426696B2 (en)	2013-03-14	2018-11-21	センプラファーマシューティカルズ，インコーポレイテッド	Methods and formulations for the treatment of respiratory diseases
CA2907085A1 (en)	2013-03-15	2014-09-18	Cempra Pharmaceuticals, Inc.	Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2727969B1 (en) *	1994-12-09	1997-01-17	Roussel Uclaf	NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2745290B1 (en) *	1996-02-28	1998-04-03	Roussel Uclaf	NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
AU6421398A (en) *	1997-03-24	1998-10-20	Taisho Pharmaceutical Co., Ltd.	Erythromycin a derivatives

2000
- 2000-07-31 WO PCT/JP2000/005144 patent/WO2001010878A1/en active Application Filing
- 2000-07-31 AU AU61837/00A patent/AU6183700A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2001010878A1 (en)	2001-02-15

Legal Events

Date	Code	Title	Description
2002-05-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

Publication	Publication Date	Title
AU6314900A (en)	2001-02-13	Biarylurea derivatives
AU6714700A (en)	2001-03-26	Cyclopropylindole derivatives
AUPQ376399A0 (en)	1999-11-25	A structural member
AU9277698A (en)	1999-05-17	9-amino-3-keto erythromycin derivatives
AU4473097A (en)	1998-06-22	Erythromycin a derivatives
NZ513998A (en)	2001-09-28	Erythromycin derivatives
AU6183700A (en)	2001-03-05	Erythromycin a derivatives
AU7952800A (en)	2001-04-30	2-alkoxybenzene derivatives
AU6421398A (en)	1998-10-20	Erythromycin a derivatives
AU9646098A (en)	1999-05-17	Erythromycin a derivatives
AU8925398A (en)	1999-03-22	3-descladinose 6-o-substituded erythromycin derivatives
AUPQ215199A0 (en)	1999-09-02	A barrier
AU8018200A (en)	2001-05-14	A knowledge-engineering protocol-suite
AU4472897A (en)	1998-09-29	Erythromycin a derivatives
AU6316400A (en)	2001-03-05	Erythromycin a derivatives
AU6183800A (en)	2001-03-05	Erythromycin a derivatives
AU6932098A (en)	1998-12-08	Erythromycin derivatives
AU1504899A (en)	1999-06-28	Erythromycin derivatives
AU6262300A (en)	2001-01-02	Indolinylamide derivatives
AU1558300A (en)	2001-03-05	1-cycloalkylpyrazoyl-benzoyl derivatives
AU4222797A (en)	1998-04-17	Erythromycin a derivatives
AU6748400A (en)	2001-02-19	A single-compiler architecture
AU5666800A (en)	2001-01-09	Difuropyrone derivatives
AU4472797A (en)	1998-05-22	Erythromycin a derivatives
AU4472697A (en)	1998-05-22	Erythromycin a derivatives